The symptoms often follow a pattern where: Many patients report improvement in nausea and malaise after the first few weeks Symptoms often become more manageable or resolve completely with continued treatment Some patients may experience mild symptoms that persist longer, though these typically become less bothersome over time Factors affecting duration: Several variables influence how long symptoms persist: Dose escalation schedule slower titration (gradual dose increases) typically results in fewer and shorter-lasting symptoms Individual sensitivity some patients are more susceptible to gastrointestinal side effects Concurrent medications other drugs affecting the GI tract may prolong symptoms Dietary habits eating patterns and food choices can influence symptom severity and duration It is worth noting that symptoms may temporarily recur when the dose is increased according to the recommended schedule (which varies by product weekly for liraglutide, every 4 weeks for weekly semaglutide), but subsequent episodes are often less severe than the initial experience
National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD Baecke JA, Burema J, Frijters JE (1982) A short questionnaire for the measurement of habitual physical activity in epidemiological studies
When a person first starts a GLP-1 RA, they often experience side effects
Research has shown the neurodegenerative disease can impair walking and their ability to turn safely, resulting in people being especially susceptible to injuries associated with falls
That track record underpins an immaculate reputation with a simple promise: whats on the label is whats in the bottle, and its lawful to buy and use
